Novartis Investigative Site is a clinical research site located in Kalamazoo, Michigan, United States 49008.
Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.
Novartis Investigative Site has participated in 17 clinical trials with 1 currently active.
Therapeutic areas: Alzheimers Disease, Relapsing Remitting Multiple Sclerosis, Psoriatic Arthritis.
Sponsors: Novartis Pharmaceuticals.
Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Novartis Investigative Site has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Novartis Investigative Site has 17 clinical trials on record, with 1 currently active. Their work covers Alzheimers Disease, Relapsing Remitting Multiple Sclerosis, Psoriatic Arthritis.
Yes — Novartis Investigative Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.